Clearasil Blackhead Control
Natural health product licensed in Canada
- Licence holder
- Reckitt Benckiser (Canada) Inc.
- NPN or DIN-HM
- 80002170
- Status
- Inactive licence
- Licence date
- 28 September 2006
- Revision date
- Not provided
- Form
- Tampon
- Route of administration
- Topique
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Acide salicylique | 2 % |
Non-medicinal ingredients
Isobutyl paraben, Cétéareth-12, Parahydroxybenzoate de méthyle, Eau, Glycérine, Dipropylene glycol, Phénoxyéthanol, Hydroxyde de sodium, Alcool cétéarylique, cetearyl isononanoate, EDTA de tétrasodium, propylèneglycol, Ceteareth-20, Maris sal, (p)-hydroxybenzoate de butyle, Stéarate de glycéryle, Octyldodecanol, (p)-hydroxybenzoate de propyle, Perfume, Palmitate de cétyle, Poly(sorbate) 20, Ethylparaben
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Sous-population S/O | Not specified | Not specified | 2 Tous les jours |
Uses authorised in Canada
Blackhead control, acne fighting, helps clear breakouts and prevent new ones from forming.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
WARNINGS: For external use only. Do not use with other acne medications except on the advice of a doctor. If excessive skin irritation develops or increases, discontinue use; if irritation persists consult a doctor. Avoid contact with eyes. If contact occurs, rinse throughly with water. In case of accidental ingestion, get medical help or contact a poison control center immediately. KEEP OUT OF REACH OF CHILDREN.
- Effets indésirables connus
Dryness or irritation of the skin.
Source
Official Health Canada record, licence 80002170
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.